By proceeding, you agree to our Terms of Use and Privacy Policy.
Global Engage is pleased to announce the 5th Global NASH Congress, which will be taking place on the 14th and 15th of March 2022 in London. An increasing number of people are being diagnosed with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) each year, and the primary method of treatment is weight loss.
The 5th Global NASH Congress will discuss drug development and treatment pathways for nonalcoholic steatohepatitis (NASH). The event offers group discounts!
Some key developments under the lens are improved in vivo liver models, non-invasive diagnostic biomarkers and better understanding of the NASH disease’s mechanisms.
Participate in Speaker-led NASH brainstorming sessions. Industry and academic presenters can also stage their own poster presentations on the topic!
Producing high level conferences and summits for the Pharmaceutical, Medical and Agricultural Biotechnology sectors our experienced team of researchers provides you with the opportunity to share knowledge, network and most importantly find sources of
SomaLogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected, diagnosed and managed.
We are the AI platform company that elevates computational pathology to guide better drug development and diagnostics
Resonance Health is a global leader in the development and delivery of non-invasive diagnostic medical imaging solutions.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.